Cargando…

Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders

BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Langenbach, Tobias, Spönlein, Alexandra, Overfeld, Eva, Wiltfang, Gaby, Quecke, Niklas, Scherbaum, Norbert, Melchers, Peter, Hebebrand, Johannes
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956714/
https://www.ncbi.nlm.nih.gov/pubmed/20920182
http://dx.doi.org/10.1186/1753-2000-4-25
_version_ 1782188181023621120
author Langenbach, Tobias
Spönlein, Alexandra
Overfeld, Eva
Wiltfang, Gaby
Quecke, Niklas
Scherbaum, Norbert
Melchers, Peter
Hebebrand, Johannes
author_facet Langenbach, Tobias
Spönlein, Alexandra
Overfeld, Eva
Wiltfang, Gaby
Quecke, Niklas
Scherbaum, Norbert
Melchers, Peter
Hebebrand, Johannes
author_sort Langenbach, Tobias
collection PubMed
description BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and standardized clinical questionnaires to assess mental disorders, symptom distress, psychosocial variables and detailed aspects of drug use. A consecutively referred subgroup of these 151 patients consisting of 65 underage patients (mean age 16.12, SD = 1.10; range 13 - 17) was additionally assessed with the modules for attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) using The Schedule for Affective Disorders and Schizophrenia for school-aged children (K-SADS-PL). RESULTS: 128 (84.8%) of the 151 patients were dependent on at least one substance, the remaining patients fulfilled diagnostic criteria for abuse only. 40.5% of the participants fulfilled criteria for at least one comorbid present Axis I disorder other than substance use disorders (67.7% in the subgroup additionally interviewed with the K-SADS-PL). High prevalences of present mood disorder (19.2%), somatoform disorders (9.3%), and anxiety disorders (22.5%) were found. The 37 female participants showed a significantly higher risk for lifetime comorbid disorders; the gender difference was significantly pronounced for anxiety and somatoform disorders. Data from the underage subgroup revealed a high prevalence for present CD (41.5%). 33% of the 106 patients (total group) who were within the mandatory school age had not attended school for at least a two-month period prior to admission. In addition, 51.4% had been temporarily expelled from school at least once. CONCLUSIONS: The present data validates previous findings of high psychiatric comorbidity in adolescent patients with substance use disorders. The high rates of school refusal and conduct disorder indicate the severity of psychosocial impairment.
format Text
id pubmed-2956714
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29567142010-10-19 Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders Langenbach, Tobias Spönlein, Alexandra Overfeld, Eva Wiltfang, Gaby Quecke, Niklas Scherbaum, Norbert Melchers, Peter Hebebrand, Johannes Child Adolesc Psychiatry Ment Health Research BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and standardized clinical questionnaires to assess mental disorders, symptom distress, psychosocial variables and detailed aspects of drug use. A consecutively referred subgroup of these 151 patients consisting of 65 underage patients (mean age 16.12, SD = 1.10; range 13 - 17) was additionally assessed with the modules for attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) using The Schedule for Affective Disorders and Schizophrenia for school-aged children (K-SADS-PL). RESULTS: 128 (84.8%) of the 151 patients were dependent on at least one substance, the remaining patients fulfilled diagnostic criteria for abuse only. 40.5% of the participants fulfilled criteria for at least one comorbid present Axis I disorder other than substance use disorders (67.7% in the subgroup additionally interviewed with the K-SADS-PL). High prevalences of present mood disorder (19.2%), somatoform disorders (9.3%), and anxiety disorders (22.5%) were found. The 37 female participants showed a significantly higher risk for lifetime comorbid disorders; the gender difference was significantly pronounced for anxiety and somatoform disorders. Data from the underage subgroup revealed a high prevalence for present CD (41.5%). 33% of the 106 patients (total group) who were within the mandatory school age had not attended school for at least a two-month period prior to admission. In addition, 51.4% had been temporarily expelled from school at least once. CONCLUSIONS: The present data validates previous findings of high psychiatric comorbidity in adolescent patients with substance use disorders. The high rates of school refusal and conduct disorder indicate the severity of psychosocial impairment. BioMed Central 2010-09-28 /pmc/articles/PMC2956714/ /pubmed/20920182 http://dx.doi.org/10.1186/1753-2000-4-25 Text en Copyright ©2010 Langenbach et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Langenbach, Tobias
Spönlein, Alexandra
Overfeld, Eva
Wiltfang, Gaby
Quecke, Niklas
Scherbaum, Norbert
Melchers, Peter
Hebebrand, Johannes
Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title_full Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title_fullStr Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title_full_unstemmed Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title_short Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
title_sort axis i comorbidity in adolescent inpatients referred for treatment of substance use disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956714/
https://www.ncbi.nlm.nih.gov/pubmed/20920182
http://dx.doi.org/10.1186/1753-2000-4-25
work_keys_str_mv AT langenbachtobias axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT sponleinalexandra axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT overfeldeva axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT wiltfanggaby axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT queckeniklas axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT scherbaumnorbert axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT melcherspeter axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders
AT hebebrandjohannes axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders